

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.59802479 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.59802479 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.27433415 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.27433415 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.68729110 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.51701576 |
| 7 | regulation of plasminogen activation (GO:0010755) | 6.14950684 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.90987074 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.90987074 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.90987074 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.79087235 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.76605971 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.73752829 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.73522471 |
| 15 | urea cycle (GO:0000050) | 5.60922133 |
| 16 | urea metabolic process (GO:0019627) | 5.60922133 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.58692984 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.58621255 |
| 19 | cysteine metabolic process (GO:0006534) | 5.46981493 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46822582 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.42645364 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.37536207 |
| 23 | protein carboxylation (GO:0018214) | 5.30489309 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.30489309 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.19975079 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.16627062 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.15847533 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.10432253 |
| 29 | reverse cholesterol transport (GO:0043691) | 5.01722451 |
| 30 | regulation of cholesterol esterification (GO:0010872) | 4.99296832 |
| 31 | bile acid metabolic process (GO:0008206) | 4.96041656 |
| 32 | protein-lipid complex remodeling (GO:0034368) | 4.90995277 |
| 33 | macromolecular complex remodeling (GO:0034367) | 4.90995277 |
| 34 | plasma lipoprotein particle remodeling (GO:0034369) | 4.90995277 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.90289172 |
| 36 | acute-phase response (GO:0006953) | 4.90142943 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.86640042 |
| 38 | regulation of complement activation (GO:0030449) | 4.80665699 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.78882114 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.76418080 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.76418080 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.74728197 |
| 43 | phospholipid efflux (GO:0033700) | 4.72605661 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.71157578 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.68573257 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.68573257 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.66974128 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.66974128 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.64333290 |
| 50 | epoxygenase P450 pathway (GO:0019373) | 4.62818579 |
| 51 | plasma lipoprotein particle clearance (GO:0034381) | 4.60993922 |
| 52 | lysine catabolic process (GO:0006554) | 4.58971503 |
| 53 | lysine metabolic process (GO:0006553) | 4.58971503 |
| 54 | protein-lipid complex subunit organization (GO:0071825) | 4.58775603 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.48261890 |
| 56 | glycine metabolic process (GO:0006544) | 4.47001709 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.42909130 |
| 58 | negative regulation of protein activation cascade (GO:2000258) | 4.42471301 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 4.42246763 |
| 60 | negative regulation of coagulation (GO:0050819) | 4.36870175 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.29907758 |
| 62 | cholesterol efflux (GO:0033344) | 4.28538309 |
| 63 | imidazole-containing compound metabolic process (GO:0052803) | 4.27390786 |
| 64 | negative regulation of wound healing (GO:0061045) | 4.27356085 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.25310772 |
| 66 | glutamate metabolic process (GO:0006536) | 4.23522795 |
| 67 | serine family amino acid metabolic process (GO:0009069) | 4.23096698 |
| 68 | positive regulation of blood coagulation (GO:0030194) | 4.21882795 |
| 69 | positive regulation of hemostasis (GO:1900048) | 4.21882795 |
| 70 | regulation of lipoprotein particle clearance (GO:0010984) | 4.21718606 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 4.19686115 |
| 72 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.18867250 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.16026214 |
| 74 | regulation of humoral immune response (GO:0002920) | 4.15952288 |
| 75 | plasma lipoprotein particle assembly (GO:0034377) | 4.13166259 |
| 76 | serine family amino acid biosynthetic process (GO:0009070) | 4.12769130 |
| 77 | ethanol metabolic process (GO:0006067) | 4.11711422 |
| 78 | amine catabolic process (GO:0009310) | 4.11369646 |
| 79 | cellular biogenic amine catabolic process (GO:0042402) | 4.11369646 |
| 80 | cellular glucuronidation (GO:0052695) | 4.10967806 |
| 81 | low-density lipoprotein particle remodeling (GO:0034374) | 4.09177087 |
| 82 | ethanol oxidation (GO:0006069) | 4.03876843 |
| 83 | regulation of apoptotic cell clearance (GO:2000425) | 4.03166618 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 4.00351042 |
| 85 | omega-hydroxylase P450 pathway (GO:0097267) | 3.97418925 |
| 86 | arginine metabolic process (GO:0006525) | 3.96998089 |
| 87 | aldehyde catabolic process (GO:0046185) | 3.95224415 |
| 88 | proline metabolic process (GO:0006560) | 3.94092711 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.93818716 |
| 90 | fibrinolysis (GO:0042730) | 3.92691668 |
| 91 | acute inflammatory response (GO:0002526) | 3.92329678 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.87629345 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.87629345 |
| 94 | positive regulation of coagulation (GO:0050820) | 3.86743726 |
| 95 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.84683194 |
| 96 | ketone body metabolic process (GO:1902224) | 3.82494214 |
| 97 | negative regulation of complement activation (GO:0045916) | 3.81811185 |
| 98 | negative regulation of lipase activity (GO:0060192) | 3.81009604 |
| 99 | phenylpropanoid metabolic process (GO:0009698) | 3.80538578 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.79604217 |
| 101 | cholesterol homeostasis (GO:0042632) | 3.79121814 |
| 102 | cofactor catabolic process (GO:0051187) | 3.78162263 |
| 103 | drug catabolic process (GO:0042737) | 3.77428339 |
| 104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.77401135 |
| 105 | carboxylic acid catabolic process (GO:0046395) | 3.76880099 |
| 106 | organic acid catabolic process (GO:0016054) | 3.76880099 |
| 107 | drug metabolic process (GO:0017144) | 3.76298257 |
| 108 | intestinal cholesterol absorption (GO:0030299) | 3.75819650 |
| 109 | phospholipid homeostasis (GO:0055091) | 3.75613750 |
| 110 | short-chain fatty acid metabolic process (GO:0046459) | 3.73670686 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 3.73405233 |
| 112 | sterol homeostasis (GO:0055092) | 3.72712536 |
| 113 | acylglycerol catabolic process (GO:0046464) | 3.70703844 |
| 114 | neutral lipid catabolic process (GO:0046461) | 3.70703844 |
| 115 | low-density lipoprotein particle clearance (GO:0034383) | 3.70643878 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.70560703 |
| 117 | exogenous drug catabolic process (GO:0042738) | 3.67360688 |
| 118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.67279533 |
| 119 | acetyl-CoA metabolic process (GO:0006084) | 3.66720532 |
| 120 | positive regulation of steroid metabolic process (GO:0045940) | 3.65111240 |
| 121 | glucuronate metabolic process (GO:0019585) | 3.64165836 |
| 122 | uronic acid metabolic process (GO:0006063) | 3.64165836 |
| 123 | diacylglycerol metabolic process (GO:0046339) | 3.63613468 |
| 124 | complement activation, classical pathway (GO:0006958) | 3.63385748 |
| 125 | complement activation (GO:0006956) | 3.61213215 |
| 126 | protein activation cascade (GO:0072376) | 3.61159691 |
| 127 | positive regulation of extracellular matrix organization (GO:1903055) | 3.58970008 |
| 128 | regulation of cholesterol homeostasis (GO:2000188) | 3.57387227 |
| 129 | aspartate family amino acid catabolic process (GO:0009068) | 3.52488080 |
| 130 | cytolysis (GO:0019835) | 3.52394447 |
| 131 | fatty acid homeostasis (GO:0055089) | 3.48863783 |
| 132 | lipoprotein metabolic process (GO:0042157) | 3.45510447 |
| 133 | triglyceride catabolic process (GO:0019433) | 3.40191149 |
| 134 | sterol transport (GO:0015918) | 3.37409985 |
| 135 | cholesterol transport (GO:0030301) | 3.37409985 |
| 136 | oxidative demethylation (GO:0070989) | 3.35966792 |
| 137 | regulation of triglyceride metabolic process (GO:0090207) | 3.34258230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.33726588 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18336134 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.89678513 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46907833 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.26886080 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.20019843 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.12260691 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.97439588 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.95531797 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14643409 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.05960391 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03292371 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9264963 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64392570 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.61943745 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57775152 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52744224 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47479690 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39275414 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35417271 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23704106 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23443027 |
| 23 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20908697 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.20212970 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11652123 |
| 26 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03270971 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02931876 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02593108 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98251952 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97186828 |
| 31 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96719429 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.95114591 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93576916 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92863992 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91056952 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91046522 |
| 37 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.90925759 |
| 38 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88047678 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86556707 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83729815 |
| 41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83086930 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81364438 |
| 43 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80186915 |
| 44 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78946255 |
| 45 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78095403 |
| 46 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.76813781 |
| 47 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75869514 |
| 48 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.74242374 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73560064 |
| 50 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72779349 |
| 51 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.72145177 |
| 52 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71995517 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.71625137 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.71608707 |
| 55 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.71480023 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71464669 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71424177 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71239182 |
| 59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.70465777 |
| 60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.69515404 |
| 61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.68879040 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 0.68583911 |
| 63 | P68_20966046_ChIP-Seq_HELA_Human | 0.67394692 |
| 64 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.66887628 |
| 65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66823869 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65858391 |
| 67 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65736801 |
| 68 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65575036 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65504796 |
| 70 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.65214639 |
| 71 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65149545 |
| 72 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.64741791 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.64575438 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63566646 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.62911277 |
| 76 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.62767975 |
| 77 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62505725 |
| 78 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.62004097 |
| 79 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.61682793 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.61590695 |
| 81 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.60739962 |
| 82 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.60694293 |
| 83 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.59713018 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.59646740 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.59531736 |
| 86 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59419764 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.59411101 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.59411101 |
| 89 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58591827 |
| 90 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.58079367 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57008549 |
| 92 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.56860608 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.54515333 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.53989287 |
| 95 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.53946321 |
| 96 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.53598787 |
| 97 | ERA_21632823_ChIP-Seq_H3396_Human | 0.53399152 |
| 98 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53101015 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.52968649 |
| 100 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52449413 |
| 101 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52194315 |
| 102 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51454710 |
| 103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51340813 |
| 104 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51319576 |
| 105 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.50987001 |
| 106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.50625598 |
| 107 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50378870 |
| 108 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.48935728 |
| 109 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48103385 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.47311774 |
| 111 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45848750 |
| 112 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45567365 |
| 113 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45461494 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.44977898 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44819399 |
| 116 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44134831 |
| 117 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43332670 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42788949 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42427399 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41872657 |
| 121 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41820047 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41796538 |
| 123 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40174507 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39632090 |
| 125 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37361285 |
| 126 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.36486953 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.36396219 |
| 128 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36003374 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.35572280 |
| 130 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35466462 |
| 131 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.35286815 |
| 132 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.35230985 |
| 133 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35023388 |
| 134 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.34975293 |
| 135 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.34612628 |
| 136 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.34608793 |
| 137 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.33934872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.22543058 |
| 2 | MP0005360_urolithiasis | 7.43400891 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.35302228 |
| 4 | MP0005365_abnormal_bile_salt | 6.28021443 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.96664006 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.18471818 |
| 7 | MP0003252_abnormal_bile_duct | 3.76141948 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.67347380 |
| 9 | MP0005083_abnormal_biliary_tract | 3.40982096 |
| 10 | MP0009840_abnormal_foam_cell | 3.34809847 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.89394014 |
| 12 | MP0005332_abnormal_amino_acid | 2.76409780 |
| 13 | MP0003195_calcinosis | 2.76027577 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.35494667 |
| 15 | MP0002118_abnormal_lipid_homeostasis | 2.17052678 |
| 16 | MP0000609_abnormal_liver_physiology | 2.16975765 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.09614471 |
| 18 | MP0003122_maternal_imprinting | 1.96425606 |
| 19 | MP0003868_abnormal_feces_composition | 1.96393477 |
| 20 | MP0000566_synostosis | 1.88091707 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.85362507 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.81534793 |
| 23 | MP0001764_abnormal_homeostasis | 1.69680063 |
| 24 | MP0009697_abnormal_copulation | 1.60353444 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56126329 |
| 26 | MP0005451_abnormal_body_composition | 1.45801163 |
| 27 | MP0003186_abnormal_redox_activity | 1.32383288 |
| 28 | MP0003011_delayed_dark_adaptation | 1.31577914 |
| 29 | MP0002089_abnormal_postnatal_growth/wei | 1.30843900 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.26122282 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.25670630 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.23835163 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.23669696 |
| 34 | MP0000598_abnormal_liver_morphology | 1.18375740 |
| 35 | MP0001915_intracranial_hemorrhage | 1.13541389 |
| 36 | MP0005647_abnormal_sex_gland | 1.11752030 |
| 37 | MP0000604_amyloidosis | 1.09494540 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.08419157 |
| 39 | MP0000003_abnormal_adipose_tissue | 1.06432395 |
| 40 | MP0005375_adipose_tissue_phenotype | 1.05243837 |
| 41 | MP0004185_abnormal_adipocyte_glucose | 1.02222291 |
| 42 | MP0002132_abnormal_respiratory_system | 1.02118591 |
| 43 | MP0009763_increased_sensitivity_to | 1.01262273 |
| 44 | MP0002254_reproductive_system_inflammat | 1.01228398 |
| 45 | MP0005220_abnormal_exocrine_pancreas | 1.00069235 |
| 46 | MP0009764_decreased_sensitivity_to | 0.98742502 |
| 47 | MP0010368_abnormal_lymphatic_system | 0.95606122 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 0.94298850 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 0.91752785 |
| 50 | MP0003879_abnormal_hair_cell | 0.91553775 |
| 51 | MP0008469_abnormal_protein_level | 0.88409339 |
| 52 | MP0003172_abnormal_lysosome_physiology | 0.88341638 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 0.87824940 |
| 54 | MP0009642_abnormal_blood_homeostasis | 0.87731851 |
| 55 | MP0005408_hypopigmentation | 0.85250590 |
| 56 | MP0002078_abnormal_glucose_homeostasis | 0.84222990 |
| 57 | MP0002876_abnormal_thyroid_physiology | 0.82228347 |
| 58 | MP0005376_homeostasis/metabolism_phenot | 0.79530768 |
| 59 | MP0005670_abnormal_white_adipose | 0.79232743 |
| 60 | MP0004130_abnormal_muscle_cell | 0.78405605 |
| 61 | MP0009765_abnormal_xenobiotic_induced | 0.78390768 |
| 62 | MP0002971_abnormal_brown_adipose | 0.77909628 |
| 63 | MP0004272_abnormal_basement_membrane | 0.76296279 |
| 64 | MP0005334_abnormal_fat_pad | 0.74606868 |
| 65 | MP0005535_abnormal_body_temperature | 0.73956005 |
| 66 | MP0010386_abnormal_urinary_bladder | 0.71088056 |
| 67 | MP0001661_extended_life_span | 0.68218416 |
| 68 | MP0003329_amyloid_beta_deposits | 0.65761385 |
| 69 | MP0005448_abnormal_energy_balance | 0.65316677 |
| 70 | MP0003690_abnormal_glial_cell | 0.65075739 |
| 71 | MP0005266_abnormal_metabolism | 0.64099545 |
| 72 | MP0009053_abnormal_anal_canal | 0.63692199 |
| 73 | MP0002909_abnormal_adrenal_gland | 0.62514911 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 0.62140028 |
| 75 | MP0000639_abnormal_adrenal_gland | 0.60871817 |
| 76 | MP0005257_abnormal_intraocular_pressure | 0.58461990 |
| 77 | MP0001756_abnormal_urination | 0.57206265 |
| 78 | MP0003123_paternal_imprinting | 0.56760914 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 0.56469006 |
| 80 | MP0006035_abnormal_mitochondrial_morpho | 0.54549623 |
| 81 | MP0008438_abnormal_cutaneous_collagen | 0.52428289 |
| 82 | MP0003638_abnormal_response/metabolism_ | 0.50864171 |
| 83 | MP0003567_abnormal_fetal_cardiomyocyte | 0.50722638 |
| 84 | MP0005464_abnormal_platelet_physiology | 0.49825541 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.49039460 |
| 86 | MP0002822_catalepsy | 0.47388731 |
| 87 | MP0002933_joint_inflammation | 0.46288175 |
| 88 | MP0003953_abnormal_hormone_level | 0.45262786 |
| 89 | MP0005395_other_phenotype | 0.45096767 |
| 90 | MP0003718_maternal_effect | 0.44726097 |
| 91 | MP0002928_abnormal_bile_duct | 0.43960922 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.42988488 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.42902118 |
| 94 | MP0008873_increased_physiological_sensi | 0.42812907 |
| 95 | MP0008874_decreased_physiological_sensi | 0.42713647 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.42222072 |
| 97 | MP0003724_increased_susceptibility_to | 0.41701661 |
| 98 | MP0003436_decreased_susceptibility_to | 0.41364144 |
| 99 | MP0003075_altered_response_to | 0.40703149 |
| 100 | MP0009672_abnormal_birth_weight | 0.40662085 |
| 101 | MP0005452_abnormal_adipose_tissue | 0.40444855 |
| 102 | MP0000858_altered_metastatic_potential | 0.40307990 |
| 103 | MP0005377_hearing/vestibular/ear_phenot | 0.38177891 |
| 104 | MP0003878_abnormal_ear_physiology | 0.38177891 |
| 105 | MP0008872_abnormal_physiological_respon | 0.37899879 |
| 106 | MP0002970_abnormal_white_adipose | 0.36901086 |
| 107 | MP0005248_abnormal_Harderian_gland | 0.36463141 |
| 108 | MP0009115_abnormal_fat_cell | 0.35970185 |
| 109 | MP0002796_impaired_skin_barrier | 0.35338203 |
| 110 | MP0002249_abnormal_larynx_morphology | 0.34962961 |
| 111 | MP0005166_decreased_susceptibility_to | 0.34946471 |
| 112 | MP0005409_darkened_coat_color | 0.34391040 |
| 113 | MP0002090_abnormal_vision | 0.33567877 |
| 114 | MP0001243_abnormal_dermal_layer | 0.33457563 |
| 115 | MP0000249_abnormal_blood_vessel | 0.33072047 |
| 116 | MP0000920_abnormal_myelination | 0.32585086 |
| 117 | MP0003950_abnormal_plasma_membrane | 0.32078724 |
| 118 | MP0001881_abnormal_mammary_gland | 0.30747665 |
| 119 | MP0003959_abnormal_lean_body | 0.30544960 |
| 120 | MP0000579_abnormal_nail_morphology | 0.30319270 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.30297210 |
| 122 | MP0004883_abnormal_blood_vessel | 0.30090725 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.29335626 |
| 124 | MP0001845_abnormal_inflammatory_respons | 0.28846790 |
| 125 | MP0005023_abnormal_wound_healing | 0.28821093 |
| 126 | MP0001944_abnormal_pancreas_morphology | 0.27863805 |
| 127 | MP0004381_abnormal_hair_follicle | 0.27607546 |
| 128 | MP0002168_other_aberrant_phenotype | 0.27375327 |
| 129 | MP0001853_heart_inflammation | 0.26412976 |
| 130 | MP0006082_CNS_inflammation | 0.26160140 |
| 131 | MP0002060_abnormal_skin_morphology | 0.25947602 |
| 132 | MP0005164_abnormal_response_to | 0.25334409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.46656930 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.38446828 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.06928354 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.50847875 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.50310594 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.48593507 |
| 7 | Xanthomatosis (HP:0000991) | 6.26856347 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.64815839 |
| 9 | Complement deficiency (HP:0004431) | 5.13374207 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.87884153 |
| 11 | Joint hemorrhage (HP:0005261) | 4.76926506 |
| 12 | Hyperammonemia (HP:0001987) | 4.63070207 |
| 13 | Hyperglycinemia (HP:0002154) | 4.50332162 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.46148384 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.44944076 |
| 16 | Epidermoid cyst (HP:0200040) | 4.44246684 |
| 17 | Ketosis (HP:0001946) | 4.38765848 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.25442236 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 4.23367315 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21954803 |
| 21 | Fat malabsorption (HP:0002630) | 4.17482290 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.13481508 |
| 23 | Hyperglycinuria (HP:0003108) | 4.11851534 |
| 24 | Hypoglycemic coma (HP:0001325) | 4.10004960 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.07711270 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.07711270 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.07483874 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.89663638 |
| 29 | Abnormality of complement system (HP:0005339) | 3.74421122 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.69853039 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.61286776 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.54284709 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.43341313 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.40966845 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.28160786 |
| 36 | Steatorrhea (HP:0002570) | 3.20748429 |
| 37 | Ketoacidosis (HP:0001993) | 3.18407448 |
| 38 | Purpura (HP:0000979) | 3.16598604 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.10975657 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.08137248 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01118680 |
| 42 | Myocardial infarction (HP:0001658) | 2.99055254 |
| 43 | Nephritis (HP:0000123) | 2.97017711 |
| 44 | Spontaneous abortion (HP:0005268) | 2.91787438 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.90536730 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.86211339 |
| 47 | Metabolic acidosis (HP:0001942) | 2.80084781 |
| 48 | Skin nodule (HP:0200036) | 2.76028461 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 2.70451929 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.70451929 |
| 51 | Hypoglycemic seizures (HP:0002173) | 2.67764890 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.66751500 |
| 53 | Lethargy (HP:0001254) | 2.65245297 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.63174282 |
| 55 | Acanthocytosis (HP:0001927) | 2.55225988 |
| 56 | Vascular calcification (HP:0004934) | 2.54314322 |
| 57 | Gout (HP:0001997) | 2.51335468 |
| 58 | Cerebral edema (HP:0002181) | 2.50637009 |
| 59 | Facial shape deformation (HP:0011334) | 2.47508771 |
| 60 | Potter facies (HP:0002009) | 2.47508771 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.47471299 |
| 62 | Spastic diplegia (HP:0001264) | 2.43263912 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.40547357 |
| 64 | Glomerulonephritis (HP:0000099) | 2.38989425 |
| 65 | Mitral stenosis (HP:0001718) | 2.35486273 |
| 66 | Abnormality of carpal bone ossification (HP:0006257) | 2.34180988 |
| 67 | Cholelithiasis (HP:0001081) | 2.33835298 |
| 68 | Neonatal onset (HP:0003623) | 2.30572616 |
| 69 | Amyloidosis (HP:0011034) | 2.30367956 |
| 70 | Irritability (HP:0000737) | 2.29139319 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.25921068 |
| 72 | Pancreatitis (HP:0001733) | 2.25900279 |
| 73 | Hypertriglyceridemia (HP:0002155) | 2.22726715 |
| 74 | Osteomalacia (HP:0002749) | 2.22166594 |
| 75 | Malnutrition (HP:0004395) | 2.21543455 |
| 76 | Late onset (HP:0003584) | 2.21537463 |
| 77 | Esophageal varix (HP:0002040) | 2.20849575 |
| 78 | Abnormality of the Achilles tendon (HP:0005109) | 2.20736678 |
| 79 | Pulmonary embolism (HP:0002204) | 2.19744690 |
| 80 | Abnormal gallbladder physiology (HP:0012438) | 2.19697261 |
| 81 | Cholecystitis (HP:0001082) | 2.19697261 |
| 82 | Asymmetry of the thorax (HP:0001555) | 2.18737211 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18015880 |
| 84 | Menorrhagia (HP:0000132) | 2.17255851 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.16697828 |
| 86 | Brushfield spots (HP:0001088) | 2.15529122 |
| 87 | Increased serum pyruvate (HP:0003542) | 2.14635333 |
| 88 | Gingival bleeding (HP:0000225) | 2.14301830 |
| 89 | Vomiting (HP:0002013) | 2.11634753 |
| 90 | Sensorimotor neuropathy (HP:0007141) | 2.07513838 |
| 91 | Generalized aminoaciduria (HP:0002909) | 2.07161316 |
| 92 | Thrombophlebitis (HP:0004418) | 2.06086790 |
| 93 | Enlarged kidneys (HP:0000105) | 2.05987837 |
| 94 | Arthropathy (HP:0003040) | 2.04168308 |
| 95 | Opisthotonus (HP:0002179) | 2.03840736 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.00635681 |
| 97 | Poikilocytosis (HP:0004447) | 1.99437373 |
| 98 | Hydroxyprolinuria (HP:0003080) | 1.96394464 |
| 99 | Abnormality of proline metabolism (HP:0010907) | 1.96394464 |
| 100 | Abnormality of the gallbladder (HP:0005264) | 1.94700357 |
| 101 | Abnormal cartilage morphology (HP:0002763) | 1.93130346 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 1.92972613 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92874930 |
| 104 | Protrusio acetabuli (HP:0003179) | 1.92138091 |
| 105 | Abnormality of glycolysis (HP:0004366) | 1.87328287 |
| 106 | Rickets (HP:0002748) | 1.85046359 |
| 107 | Polycythemia (HP:0001901) | 1.84948358 |
| 108 | Renal cortical cysts (HP:0000803) | 1.84589430 |
| 109 | Growth hormone excess (HP:0000845) | 1.84347459 |
| 110 | Retinal atrophy (HP:0001105) | 1.82558269 |
| 111 | Bifid scrotum (HP:0000048) | 1.82542060 |
| 112 | Hyperglycemia (HP:0003074) | 1.80537282 |
| 113 | Hypophosphatemic rickets (HP:0004912) | 1.79518615 |
| 114 | Elevated hepatic transaminases (HP:0002910) | 1.79142372 |
| 115 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.78010595 |
| 116 | Alkalosis (HP:0001948) | 1.76077594 |
| 117 | Acute hepatic failure (HP:0006554) | 1.74500779 |
| 118 | Abnormality of vitamin metabolism (HP:0100508) | 1.74054815 |
| 119 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73877004 |
| 120 | Widely patent fontanelles and sutures (HP:0004492) | 1.73322853 |
| 121 | Symptomatic seizures (HP:0011145) | 1.73038552 |
| 122 | Increased serum ferritin (HP:0003281) | 1.68910245 |
| 123 | Vertebral compression fractures (HP:0002953) | 1.67359498 |
| 124 | Abnormal hand bone ossification (HP:0010660) | 1.66837015 |
| 125 | Abnormal tarsal ossification (HP:0008369) | 1.66581862 |
| 126 | Abnormal ossification of hand bones (HP:0005921) | 1.66467827 |
| 127 | Acanthosis nigricans (HP:0000956) | 1.65939280 |
| 128 | Proximal tubulopathy (HP:0000114) | 1.64876342 |
| 129 | Gangrene (HP:0100758) | 1.61759382 |
| 130 | Paraparesis (HP:0002385) | 1.60618669 |
| 131 | Epistaxis (HP:0000421) | 1.60284352 |
| 132 | Back pain (HP:0003418) | 1.59696824 |
| 133 | Abnormality of pain sensation (HP:0010832) | 1.57431098 |
| 134 | Impaired pain sensation (HP:0007328) | 1.57431098 |
| 135 | Menstrual irregularities (HP:0000858) | 1.57144169 |
| 136 | Flat acetabular roof (HP:0003180) | 1.55607796 |
| 137 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.52964114 |
| 138 | Mucopolysacchariduria (HP:0008155) | 1.52964114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.76778408 |
| 2 | SIK1 | 5.04053299 |
| 3 | ERN1 | 4.56826455 |
| 4 | FGFR4 | 4.37100593 |
| 5 | TESK2 | 4.05354641 |
| 6 | INSRR | 2.84402307 |
| 7 | TAOK3 | 2.80686912 |
| 8 | ERBB4 | 2.62123846 |
| 9 | PKN2 | 2.47432450 |
| 10 | MST1R | 2.10117658 |
| 11 | TRIB3 | 2.09874664 |
| 12 | WNK4 | 2.08039362 |
| 13 | MAP2K4 | 2.04996007 |
| 14 | PDGFRA | 1.97107365 |
| 15 | FLT3 | 1.95288513 |
| 16 | PIK3CG | 1.83219849 |
| 17 | MAPK11 | 1.77783812 |
| 18 | DDR2 | 1.73250545 |
| 19 | MAPKAPK3 | 1.66096476 |
| 20 | TYK2 | 1.58047422 |
| 21 | DAPK2 | 1.55858189 |
| 22 | PTK6 | 1.49476740 |
| 23 | TYRO3 | 1.48943021 |
| 24 | LATS1 | 1.44419049 |
| 25 | FRK | 1.36421251 |
| 26 | ABL2 | 1.35850892 |
| 27 | KDR | 1.31462221 |
| 28 | FGFR1 | 1.30783200 |
| 29 | NEK9 | 1.29474796 |
| 30 | FGFR2 | 1.25915550 |
| 31 | JAK2 | 1.17073364 |
| 32 | PRKAA2 | 1.11996622 |
| 33 | MAP3K7 | 1.11426547 |
| 34 | PINK1 | 1.09988816 |
| 35 | GRK6 | 1.07655405 |
| 36 | MAP2K3 | 1.05008923 |
| 37 | TBK1 | 0.99956072 |
| 38 | MAPK15 | 0.97803978 |
| 39 | CAMK1D | 0.96138229 |
| 40 | MAP3K10 | 0.94402799 |
| 41 | JAK1 | 0.92523424 |
| 42 | MAP3K3 | 0.91553818 |
| 43 | CDK12 | 0.90395609 |
| 44 | MAPK4 | 0.89288948 |
| 45 | ARAF | 0.87706340 |
| 46 | PRKCZ | 0.87432612 |
| 47 | MET | 0.86642920 |
| 48 | NTRK3 | 0.86106942 |
| 49 | ERBB2 | 0.85007735 |
| 50 | MAP3K14 | 0.84468240 |
| 51 | TIE1 | 0.80746657 |
| 52 | CDK6 | 0.79906778 |
| 53 | EEF2K | 0.79036319 |
| 54 | MAP3K11 | 0.78915694 |
| 55 | MAPK12 | 0.77882465 |
| 56 | SIK2 | 0.77521671 |
| 57 | EPHB1 | 0.75051080 |
| 58 | RIPK1 | 0.75029076 |
| 59 | PRKACG | 0.72861109 |
| 60 | DYRK1B | 0.72422171 |
| 61 | MAP2K6 | 0.71290747 |
| 62 | EIF2AK1 | 0.70122450 |
| 63 | STK38L | 0.69640779 |
| 64 | IRAK3 | 0.66487260 |
| 65 | GSK3A | 0.66273492 |
| 66 | PRKAA1 | 0.66254462 |
| 67 | CSK | 0.64301488 |
| 68 | CAMK2G | 0.63410323 |
| 69 | EPHA3 | 0.62385561 |
| 70 | WNK1 | 0.62212048 |
| 71 | SGK1 | 0.61701020 |
| 72 | STK16 | 0.60583000 |
| 73 | TGFBR2 | 0.59758019 |
| 74 | LATS2 | 0.59071767 |
| 75 | PTK2 | 0.55020281 |
| 76 | PRKG1 | 0.54947679 |
| 77 | CDK7 | 0.52869548 |
| 78 | PDPK1 | 0.52506366 |
| 79 | MAP2K1 | 0.51941176 |
| 80 | CAMKK2 | 0.51843492 |
| 81 | TAOK2 | 0.50585429 |
| 82 | FGFR3 | 0.49503460 |
| 83 | IKBKE | 0.47286761 |
| 84 | PRKCQ | 0.47268928 |
| 85 | CAMKK1 | 0.47267708 |
| 86 | MAPK7 | 0.46821056 |
| 87 | MARK2 | 0.46741800 |
| 88 | CSF1R | 0.46633856 |
| 89 | MAP2K2 | 0.46627669 |
| 90 | PRKACA | 0.46623388 |
| 91 | SGK3 | 0.44793515 |
| 92 | CSNK1G1 | 0.43812738 |
| 93 | CDC42BPA | 0.43224534 |
| 94 | MAP3K2 | 0.43008783 |
| 95 | CDK4 | 0.42635199 |
| 96 | IGF1R | 0.41167710 |
| 97 | MTOR | 0.40559102 |
| 98 | RET | 0.40154153 |
| 99 | EPHA4 | 0.39563812 |
| 100 | CSNK1E | 0.39396752 |
| 101 | SRC | 0.39075436 |
| 102 | MYLK | 0.38797442 |
| 103 | CAMK1G | 0.38742250 |
| 104 | GRK1 | 0.38517230 |
| 105 | CSNK1D | 0.37821817 |
| 106 | KSR2 | 0.37383387 |
| 107 | RPS6KA3 | 0.36826106 |
| 108 | AKT3 | 0.36092328 |
| 109 | PDK4 | 0.34784090 |
| 110 | PDK3 | 0.34784090 |
| 111 | ICK | 0.34399790 |
| 112 | MAP3K13 | 0.34291515 |
| 113 | MAP3K5 | 0.34148506 |
| 114 | CSNK2A2 | 0.33238469 |
| 115 | PDK1 | 0.32367730 |
| 116 | PRKCG | 0.31902373 |
| 117 | PIK3CA | 0.31483891 |
| 118 | SMG1 | 0.31195582 |
| 119 | PIM2 | 0.30194954 |
| 120 | PKN1 | 0.30122777 |
| 121 | CSNK2A1 | 0.29995956 |
| 122 | CAMK4 | 0.28862763 |
| 123 | EGFR | 0.28685883 |
| 124 | MUSK | 0.28168499 |
| 125 | MAP3K6 | 0.27595395 |
| 126 | PRPF4B | 0.27516758 |
| 127 | SGK2 | 0.26864869 |
| 128 | NTRK1 | 0.26674331 |
| 129 | CSNK1G2 | 0.26648080 |
| 130 | GRK5 | 0.26274969 |
| 131 | PDGFRB | 0.26172267 |
| 132 | PRKACB | 0.26045837 |
| 133 | CSNK1G3 | 0.24626428 |
| 134 | MAP3K1 | 0.23442433 |
| 135 | BMX | 0.23128024 |
| 136 | PRKCA | 0.22771288 |
| 137 | ZAP70 | 0.21929025 |
| 138 | SGK494 | 0.21867299 |
| 139 | SGK223 | 0.21867299 |
| 140 | PBK | 0.20914246 |
| 141 | MAPK3 | 0.20298844 |
| 142 | ABL1 | 0.19341527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39097973 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.58186015 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30713247 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27132384 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05373926 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70962514 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67623025 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64415340 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62066292 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.61002939 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50189697 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47241267 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19667491 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15530602 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09986860 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06276127 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03258555 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93399453 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90732717 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87899190 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87564066 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86659756 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83511533 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73142730 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72455857 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72415211 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70465394 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69162220 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64604207 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62054602 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61223104 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60035572 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58987960 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53609871 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51425950 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.45753203 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41814285 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39965242 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39618503 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.38387447 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31939311 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31484876 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31387248 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29295998 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.25007070 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23586583 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17310310 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.13902931 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10109814 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08336966 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03926362 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00877780 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99430592 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97310225 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91922094 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89219539 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85401177 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82494729 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81591047 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.79717931 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78464057 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77900658 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70865293 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67783613 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59504252 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58671273 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57862786 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57666325 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47240678 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.38998313 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.32273596 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31322924 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28620829 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27010634 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24871934 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.24237047 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21759736 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19719925 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.18631031 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16481666 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15143200 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09814965 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.05994373 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03317285 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.01223061 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00838210 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | -0.2386665 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2357747 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2348457 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2127695 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1885801 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1870631 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1786224 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1675665 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1660958 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1619293 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1547970 |
| 98 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1477172 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1430011 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1283737 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1234919 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1138371 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1074871 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1043592 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0804784 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0754644 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | -0.0747289 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0138202 |
| 109 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0055515 |

